Health Catalyst sells VitalWare for $147M, repays credit facility, Q2 revenue down 13%

Health Catalyst, Inc.

Sold VitalWare to Med-Metrix for $147M cash; used proceeds plus cash on hand to fully repay $160M credit facility.
Credit facility repayment included $122.8M term loan, $37.1M delayed draw, $3.2M prepayment premium, $0.5M accrued interest.
Q2 2026 revenue $70.5M (down 13% YoY); net loss $40.5M (vs $41.0M loss in Q2 2025).
Company expects to eliminate ~$19M annual GAAP interest expense from debt repayment.
Pro forma shows VitalWare contributed $17.6M revenue in H1 2026; Health Catalyst now focuses on intelligence products.

item 1.02 item 2.01 item 1.01 item 2.02 item 7.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.